Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974158-23-000017
Filing Date
2023-06-05
Accepted
2023-06-05 17:07:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5766
  Complete submission text file 0001974158-23-000017.txt   7357
Mailing Address 610 FIFTH AVENUE SUITE 305 NEW YORK NY 10020
Business Address 610 FIFTH AVENUE SUITE 305 NEW YORK NY 10020 212-661-3498
NSV 2017 Opportunities Fund, L.P. (Reporting) CIK: 0001698214 (see all company filings)

EIN.: 814955544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144

Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Subject) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40928 | Film No.: 23993660
SIC: 2834 Pharmaceutical Preparations